Page last updated: 2024-11-03

procainamide and Myelodysplastic Syndromes

procainamide has been researched along with Myelodysplastic Syndromes in 1 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, YS1
Shaw, AY1
Wang, SG1
Hsu, CC1
Teng, IW1
Tseng, MJ1
Huang, TH1
Chen, CS1
Leu, YW1
Hsiao, SH1

Other Studies

1 other study available for procainamide and Myelodysplastic Syndromes

ArticleYear
Identification of novel DNA methylation inhibitors via a two-component reporter gene system.
    Journal of biomedical science, 2011, Jan-10, Volume: 18

    Topics: Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Cell Line, Tumor; DNA Methylation; Drug Scr

2011